PDP2
[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 2, mitochondrial
Also known as: KIAA1348, PDP2_HUMAN, PPM2B, PPM2C2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9P2J9
- Gene
- PDP2
- Ensembl
- ENSG00000172840
- Chromosome
- 16
- Canonical length
- 529 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
This gene is a mitochondrial protein that functions as a phosphatase and is involved in the enzymatic resetting of the pyruvate dehydrogenase complex. Alternative splicing results in multiple transcript variants encoding the same protein. [provided by RefSeq, Aug 2016]
Canonical amino-acid sequenceUniProt
529 residues, UniProt reviewed canonical sequence.
>Q9P2J9|PDP2
1 MSSTVSYWIL NSTRNSIATL QGGRRLYSRY VSNRNKLKWR LFSRVPPTLN SSPCGGFTLC
61 KAYRHTSTEE DDFHLQLSPE QINEVLRAGE TTHKILDLES RVPNSVLRFE SNQLAANSPV
121 EDRRGVASCL QTNGLMFGIF DGHGGHACAQ AVSERLFYYV AVSLMSHQTL EHMEGAMESM
181 KPLLPILHWL KHPGDSIYKD VTSVHLDHLR VYWQELLDLH MEMGLSIEEA LMYSFQRLDS
241 DISLEIQAPL EDEVTRNLSL QVAFSGATAC MAHVDGIHLH VANAGDCRAI LGVQEDNGMW
301 SCLPLTRDHN AWNQAELSRL KREHPESEDR TIIMEDRLLG VLIPCRAFGD VQLKWSKELQ
361 RSILERGFNT EALNIYQFTP PHYYTPPYLT AEPEVTYHRL RPQDKFLVLA SDGLWDMLSN
421 EDVVRLVVGH LAEADWHKTD LAQRPANLGL MQSLLLQRKA SGLHEADQNA ATRLIRHAIG
481 NNEYGEMEAE RLAAMLTLPE DLARMYRDDI TVTVVYFNSE SIGAYYKGGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PDP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 8.7 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 8.7 nTPM
- kidney: 8.6 nTPM
- liver: 8 nTPM
- adipose tissue: 5.7 nTPM
- parathyroid gland: 5.7 nTPM
- duodenum: 5.1 nTPM
Single-cell type
- alveolar cells type 2: 34 nCPM
- adrenal medulla cells: 32 nCPM
- distal convoluted tubule cells: 20 nCPM
- parietal cells: 19 nCPM
- adipocytes: 19 nCPM
- retinal amacrine cells: 18 nCPM
Immune cell
- NK-cell: 4.2 nTPM
- gdT-cell: 3.8 nTPM
- memory CD8 T-cell: 3.2 nTPM
- MAIT T-cell: 3.1 nTPM
- naive CD8 T-cell: 3 nTPM
- naive CD4 T-cell: 2.6 nTPM
Brain region
- choroid plexus: 27 nTPM
- cerebellum: 24 nTPM
- pons: 24 nTPM
- thalamus: 22 nTPM
- cerebral cortex: 21 nTPM
- medulla oblongata: 20 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.97
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.3
- DepMap mean gene effect
- -0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PDP2 as an antibody target. Whether an autoantibody or antibody against PDP2 could matter depends on whether native PDP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PDP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PDP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...